Clinical and neurocognitive aspects of ...
Type de document :
Article dans une revue scientifique
PMID :
URL permanente :
Titre :
Clinical and neurocognitive aspects of hallucinations in Alzheimer’s disease
Auteur(s) :
El Haj, Mohamad [Auteur]
Laboratoire Sciences Cognitives et Sciences Affectives - UMR 9193 [SCALab]
Roche, Jean [Auteur]
Jardri, Renaud [Auteur]
Laboratoire Sciences Cognitives et Sciences Affectives - UMR 9193 [SCALab]
Kapogiannis, Dimitrios [Auteur]
Gallouj, Karim [Auteur]
Antoine, Pascal [Auteur]
Laboratoire Sciences Cognitives et Sciences Affectives - UMR 9193 [SCALab]
Laboratoire Sciences Cognitives et Sciences Affectives - UMR 9193 [SCALab]
Roche, Jean [Auteur]
Jardri, Renaud [Auteur]
Laboratoire Sciences Cognitives et Sciences Affectives - UMR 9193 [SCALab]
Kapogiannis, Dimitrios [Auteur]
Gallouj, Karim [Auteur]
Antoine, Pascal [Auteur]
Laboratoire Sciences Cognitives et Sciences Affectives - UMR 9193 [SCALab]
Titre de la revue :
Neuroscience & Biobehavioral Reviews
Nom court de la revue :
Neuroscience & Biobehavioral Reviews
Numéro :
83
Pagination :
713-720
Date de publication :
2017-02-21
ISSN :
0149-7634
Discipline(s) HAL :
Sciences cognitives
Résumé en anglais : [en]
Due to their prevalence, hallucinations are considered as one of the most frequent psychotic symptoms in Alzheimer’s disease (AD). These psychotic manifestations reduce patients’ well-being, increase the burden of caregivers, ...
Lire la suite >Due to their prevalence, hallucinations are considered as one of the most frequent psychotic symptoms in Alzheimer’s disease (AD). These psychotic manifestations reduce patients’ well-being, increase the burden of caregivers, contribute to early institutionalization, and are related with the course of cognitive decline in AD. Considering their consequences, we provide a comprehensive account of the current state of knowledge about the prevalence and characteristics of hallucinations in AD. We propose a comprehensive and testable theoretical model about hallucinations in AD: the ALZHA (ALZheimer and HAllucinations) model. In this model, neurological, genetic, cognitive, affective, and iatrogenic factors associated with hallucinations in AD are highlighted. According to the ALZHA model, hallucinations in AD first involve trait markers (i.e., cognitive deficits, neurological deficits, genetic predisposition and/or sensory deficits) to which state markers that may trigger these experiences are added (e.g., psychological distress and/or iatrogenic factors). Finally, we provide recommendations for assessment and management of these psychotic manifestations in AD, with the aim to benefit patients, caregivers, and health professionals.Lire moins >
Lire la suite >Due to their prevalence, hallucinations are considered as one of the most frequent psychotic symptoms in Alzheimer’s disease (AD). These psychotic manifestations reduce patients’ well-being, increase the burden of caregivers, contribute to early institutionalization, and are related with the course of cognitive decline in AD. Considering their consequences, we provide a comprehensive account of the current state of knowledge about the prevalence and characteristics of hallucinations in AD. We propose a comprehensive and testable theoretical model about hallucinations in AD: the ALZHA (ALZheimer and HAllucinations) model. In this model, neurological, genetic, cognitive, affective, and iatrogenic factors associated with hallucinations in AD are highlighted. According to the ALZHA model, hallucinations in AD first involve trait markers (i.e., cognitive deficits, neurological deficits, genetic predisposition and/or sensory deficits) to which state markers that may trigger these experiences are added (e.g., psychological distress and/or iatrogenic factors). Finally, we provide recommendations for assessment and management of these psychotic manifestations in AD, with the aim to benefit patients, caregivers, and health professionals.Lire moins >
Langue :
Anglais
Audience :
Non spécifiée
Établissement(s) :
Université de Lille
CNRS
CHU Lille
CNRS
CHU Lille
Équipe(s) de recherche :
Équipe Dynamique Émotionnelle et Pathologies (DEEP)
Équipe Psychiatrie & Croyance (PsyCHIC)
Équipe Psychiatrie & Croyance (PsyCHIC)
Date de dépôt :
2019-02-13T14:48:22Z
2019-12-03T16:03:38Z
2019-12-03T16:07:45Z
2021-05-20T14:27:40Z
2019-12-03T16:03:38Z
2019-12-03T16:07:45Z
2021-05-20T14:27:40Z